Top 5 Most Read RNS's on Vox Markets for Tuesday 9th May 2023
Episode 1404, May 09, 2023, 07:03 AM
Top 5 Most Read RNS's on Vox Markets for Tuesday 9th May 2023
1. Hemogenyx Pharma #HEMO - Submission of IND for HEMO-CAR-T
Hemogenyx Pharmaceuticals announces the submission of an Investigational New Drug application seeking authorization from the U.S. FDA to begin a Phase I clinical trial of its lead product candidate Chimeric Antigen Receptor T-cells for treating acute myeloid leukemia.
2. Tirupati Graphite #TGR - Unaudited Trading Results
· Total production increased by 59% YoY to 4,770 tons (FY22: 2,996 tons)
· Total Sales increased by 76% YoY to £2,890,010 (FY22: £1,645,308)
· Basket price realised per ton of graphite sold increased by 17% to £726
3. Cellular Goods #CBX - Acquisition Completion
Cellular Goods announce the completion of its acquisition of the entire issued share capital of King Tide Carbon LTD, which is to be satisfied by the issue of 95,000,000 new ordinary shares to the sole shareholder of King Tide, Matthew Lodge.
4. Echo Energy #ECHO - Proposed Partial Sale of Santa Cruz Sur Assets
Echo Energy announces the execution of a binding Term Sheet for a transaction, subject to shareholder approval, designed to provide much needed funding for the Company through the sale of 65% of the Company's 70% of the current Working Interest in Santa Cruz Sur to Selva Maria Oil S.A. and Interoil Exploration and Production ASA (the "Buyers") for a cash consideration of up to £1.725M, an award of an option to purchase a producing Columbian portfolio and the issue of equity in Echo Energy PLC at 0.065 pence per share (a more than 100% premium to the closing price on 5 May).
5. Trackwise Designs #TWD - UK EV OEM Contract Update
The delay caused by the EV OEM Change means that the planned increase in working capital associated with start of production has now been delayed and therefore the Company's previously announced cash runway to the end of May 2023 is now extended at least to the end of June 2023.
Trackwise continues to have a significant pipeline of identified IHT sales opportunities with a number of the previously identified EV cell-to-pack CCS opportunities progressing towards supplier nomination dates.
1. Hemogenyx Pharma #HEMO - Submission of IND for HEMO-CAR-T
Hemogenyx Pharmaceuticals announces the submission of an Investigational New Drug application seeking authorization from the U.S. FDA to begin a Phase I clinical trial of its lead product candidate Chimeric Antigen Receptor T-cells for treating acute myeloid leukemia.
2. Tirupati Graphite #TGR - Unaudited Trading Results
· Total production increased by 59% YoY to 4,770 tons (FY22: 2,996 tons)
· Total Sales increased by 76% YoY to £2,890,010 (FY22: £1,645,308)
· Basket price realised per ton of graphite sold increased by 17% to £726
3. Cellular Goods #CBX - Acquisition Completion
Cellular Goods announce the completion of its acquisition of the entire issued share capital of King Tide Carbon LTD, which is to be satisfied by the issue of 95,000,000 new ordinary shares to the sole shareholder of King Tide, Matthew Lodge.
4. Echo Energy #ECHO - Proposed Partial Sale of Santa Cruz Sur Assets
Echo Energy announces the execution of a binding Term Sheet for a transaction, subject to shareholder approval, designed to provide much needed funding for the Company through the sale of 65% of the Company's 70% of the current Working Interest in Santa Cruz Sur to Selva Maria Oil S.A. and Interoil Exploration and Production ASA (the "Buyers") for a cash consideration of up to £1.725M, an award of an option to purchase a producing Columbian portfolio and the issue of equity in Echo Energy PLC at 0.065 pence per share (a more than 100% premium to the closing price on 5 May).
5. Trackwise Designs #TWD - UK EV OEM Contract Update
The delay caused by the EV OEM Change means that the planned increase in working capital associated with start of production has now been delayed and therefore the Company's previously announced cash runway to the end of May 2023 is now extended at least to the end of June 2023.
Trackwise continues to have a significant pipeline of identified IHT sales opportunities with a number of the previously identified EV cell-to-pack CCS opportunities progressing towards supplier nomination dates.